Get the Stockscreener App
2.33
2.19%
0.05
Biote Corp stock is traded at $2.33, with a volume of 105.88K.
It is up +2.19% in the last 24 hours and up +2.64% over the past month.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
See More
Previous Close:
$2.28
Open:
$2.29
24h Volume:
105.88K
Relative Volume:
0.37
Market Cap:
$70.67M
Revenue:
$188.16M
Net Income/Loss:
$18.43M
P/E Ratio:
5.1778
EPS:
0.45
Net Cash Flow:
$26.45M
1W Performance:
+7.37%
1M Performance:
+2.64%
6M Performance:
-9.69%
1Y Performance:
-44.66%
1-Day Range:
$2.25
$2.35
1-Week Range:
$2.14
$2.35
52-Week Range:
$1.27
$4.7498
Biote Corp Stock (BTMD) Company Profile
Name
Biote Corp
Sector
Industry
Phone
972-486-9346
Address
1875 W. WALNUT HILL LN #100, IRVING
Compare BTMD vs MOBBW, GOODO, PSNYW, SHMD, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BTMD
Biote Corp. Class A Common Stock
|
5.89 | 33.33M | 0 | 0 | 0 | 0.00 |
MOBBW
Mobilicom Limited Warrants
|
2.50 | 3.32B | 0 | 0 | 0 | 0.00 |
GOODO
Gladstone Commercial Corporation
|
20.04 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.26 | 327.48M | 2.07B | -1.42B | -1.37B | -0.6765 |
SHMD
Schmid Group N V
|
4.45 | 292.26M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
47.47 | 0 | 0 | 0 | 0 | 0.00 |
Biote Corp Stock (BTMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-25 | Downgrade | B. Riley Securities | Buy → Neutral |
| Dec-16-24 | Initiated | Craig Hallum | Buy |
| Feb-20-24 | Initiated | B. Riley Securities | Buy |
| Feb-01-24 | Initiated | Jefferies | Buy |
| Jun-24-22 | Initiated | Cowen | Outperform |
| Jun-23-22 | Initiated | ROTH Capital | Buy |
View All
Biote Corp Stock (BTMD) Latest News
Tranche Update on biote Corp.'s Equity Buyback Plan announced on January 25, 2024. - marketscreener.com
Price to earnings forward of Biote Corp. – NASDAQ:BTMD - TradingView
Biote Corp.(NasdaqGM: BTMD) dropped from Russell 2000 Index - marketscreener.com
Biote Corp.(NasdaqGM: BTMD) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Biote Corp.(NasdaqGM: BTMD) dropped from Russell 2000 Value Benchmark - marketscreener.com
Biote Corp.(NasdaqGM: BTMD) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Biote Corp.(NasdaqGM: BTMD) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Biote Corp.(NasdaqGM: BTMD) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Biote Corp.(NasdaqGM: BTMD) dropped from Russell 3000E Value Benchmark - marketscreener.com
biote Corp. Class A Actuals & Estimates (NASDAQ:BTMD) - TradingView
BTMD Forecast — Price Target — Prediction for 2027 - TradingView
BTMD Q1 2026 Earnings: EPS Beats Estimates by 23.7% Amidst Market SkepticismRevenue Recognition Risk - dars.gov.et
Biote Corp (BTMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Biote Corp. (BTMD) Holds Steady Near Support as Slight Decline PersistsIV Contraction - dars.gov.et
Biote Corp (BTMD) Institutional Confidence - TradingKey
Biote Corp (BTMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Biote Corp (BTMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Biote Corp (BTMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Biote Corp (BTMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biote Corp (BTMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Biote Corp (BTMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biote Corp (BTMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
biote (BTMD) details salary, bonus and equity for Interim CEO Peterson - Stock Titan
biote Corp. (BTMD) interim CEO receives 206,746 stock options at $2.46 strike - Stock Titan
Biote Corp. (BTMD) Slides 2.67% as Stock Tests Key Support LevelsSmart Beta Flow - dars.gov.et
Biote Corp. (BTMD) Q1 2026 Earnings: EPS Beats Estimates by 23.71%, Stock Edges HigherHigh Growth Earnings - newsline.com
biote Corp. (BTMD) director receives 130,000 stock options at $2.34 strike - Stock Titan
biote Corp. (BTMD) Executive Chairman receives 114,157 stock options at $2.34 - Stock Titan
Biote Corp. (BTMD) Holds Steady at $2.34: Consolidation or Calm Before the Next Move?Hot Stock Picks - newsline.com
Biote Corp. Q1 2026 Earnings: EPS Beat Drives Cautious Optimism Amidst Flat Revenue DisclosureLong-Term Guidance - newsline.com
How The Evolving Story For biote (BTMD) May Shape Future Investor Expectations - Yahoo Finance
Biote Corp. (BTMD) Slides Toward Key Support Level as Selling Pressure PersistsFactor Rotation - newsline.com
Biote Appoints Bob Peterson as Interim CEO, Reaffirms 2026 Financial Guidance Amid Leadership Transition - Minichart
Biote (NASDAQ: BTMD) names interim CEO, appoints Executive Chairman and reaffirms 2026 outlook - Stock Titan
Biote appoints Bajaj as Chief Medical Officer - TipRanks
Biote Corp. (BTMD) Q1 2026 Earnings: EPS Beat Drives 4.5% Stock UptickEBITDA Analysis - The Legal Advocate
Biote names Komal Bajaj as chief medical officer - Investing.com
Biote names Komal Bajaj as chief medical officer By Investing.com - Investing.com South Africa
NYC hospital quality chief Komal Bajaj becomes Biote CMO - Stock Titan
Biote Corp. Q1 2026 Earnings: EPS Beats Estimates but Stock Declines Amid Revenue Uncertainty - newsline.com
BTMD Q1 2026 Earnings: EPS Surprises by 23.7% Despite Negative Stock ReactionStrong Earnings Momentum - newsline.com
CEO out after year leading hormone therapy company Biote - The Business Journals
Bob Peterson Named Interim CEO of Biote Corp., Effective May 28, 2026 - geneonline.com
Biote Names Its Chief Financial and Business Officer as Interim CEO - Dallas Innovates
Biote names CFO Bob Peterson as interim CEO, reaffirms FY26 outlook amid leadership shift - MSN
Biote announces Christensen to step down as CEO, Peterson named interim CEO - TipRanks
Biote names Bob Peterson interim CEO as Christensen steps down - Investing.com UK
Biote Announces Management Changes - marketscreener.com
Biote Announces Chief Executive Officer Changes - marketscreener.com
Biote Reaffirms Earnings Guidance for the Full Year 2026 - marketscreener.com
Biote names Bob Peterson as interim CEO - marketscreener.com
Biote Corp Stock (BTMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.88%
0.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):